Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IROA Technologies, University of Florida Announce Biomarker Collaboration

Published: Wednesday, July 02, 2014
Last Updated: Wednesday, July 02, 2014
Bookmark and Share
Company will support the University of Florida in a collaborative search for biomarkers of liver cancer and other liver diseases.

The collaboration will leverage the University of Florida’s Clinical and Translational Science Institute (CTSI) Biorepository, which contains a diverse collection of normal and diseased human tissues and may be used for IRB-approved research.  In addition, UF’s Southeast Center for Integrated Metabolomics (SECIM) will provide state-of the-art metabolic profiling using the IROA protocol as a foundation for exploring liver biochemical diversity and disease response.

Felice de Jong, CEO of IROA Technologies, stated, “We are pleased to be both a partner at SECIM where clients can send IROA samples for metabolic profiling analysis and now a collaborator within CTSI for biomarker discovery.  We are thrilled to be working with two such significant units within the University of Florida.  We feel this strength will assure a high probability of success. ”

IROA Technologies and UF will focus on analyzing and validating clinical tissue biomarkers in liver cancer and fatty liver disease, de Jong said, adding that UF will provide medical support and interpretation of results through an established expert liver disease and mass spectrometry Advisory Committee.  Beyond the initial discovery phases, the ability of CTSI and SECIM to support all levels of validation and testing will be critical to the long-term success of this endeavor.  

"The partnership with IROA Technologies and Dr. Chris Beecher will allow UF to develop novel methods for the identification of biomarkers for human disease. UF and the CTSI are now uniquely positioned to advance and translate metabolomics to improve health for millions of Americans," said David R. Nelson, M.D., an assistant vice president for research at UF and director of the UF CTSI.  "The relationship between IROA Technologies and SECIM keeps us at the cutting edge of new and powerful metabolomics technologies,” said Art Edison, Ph.D., Director of SECIM.

Financial and other terms of the agreement were not disclosed.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Stem Cells Rescue Patients from Mitochondrial Disease
A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.
Eco-Friendly Nanobullet to Battle Bacteria
Researchers have developed a method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!